Cheminformatic Tools and Databases for Pharmacology

session 14801 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
MAFODOTIN

BELANTAMAB MAFODOTIN-BLMF
MAFODOTIN


ATC L01XC39

ANTINEOPLASTIC
TREATMENT OF MULTIPLE MYELOMA
ANTIBODY-DRUG CONJUGATE (ADC)
MICROTUBULE INHIBITOR

INTRAVENOUS

Tmax 0.78 HOUR

VD 11 LITER

TUBULIN

Unknown - more at DrugCentralANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
SG3199

LONCASTUXIMAB TESIRINE-LPYL

ANTINEOPLASTIC
TREATMENT OF B-CELL LYMPHOMA
ANTIBODY-DRUG CONJUGATE (ADC) TARGETING CD19
PYRROLOBENZODIAZEPINE (PBD) DIMER CYTOTOXIC ALKYLAT ING AGENT

INJECTION

VD 7.11 LITER

DNA

Unknown - more at DrugCentralANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |